Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A comprehensive analysis published in PubMed Central compared metabolic and weight-loss outcomes across GLP-1based therapies
In July 2024, a retrospective study on overweight or obese adults treated for type 2 diabetes, 81.8% of people receiving tirzepatide (Mounjaro) lost at least 5% of their weight within one year compared to 66.5% of those using semaglutide (Ozempic), a significant difference (which means it did not just happen by chance)
Laboratory Testing to Guide Treatment Decisions Lab tests are vital for making B12 treatment plans
Many patients experience a frustrating array of symptomsfrom severe bloating and food intolerances to brain fog and systemic fatiguethat seem disconnected but actually share a common origin: a compromised intestinal barrier
Keep your refrigerator and pantry stocked with healthy foods that you can easily put together when its time to eat
